Overview
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Bank accounts
Registered as a VAT taxpayer on 2018-10-19. Active
26 1600 1420 1838 7924 1000 0001
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
7 public aid cases recorded, with a total value of $52,216.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| May 11, 2021 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | —— | PIERWSZY URZĄD SKARBOWY WARSZAWA-ŚRÓDMIEŚCIE | |
| Dec 10, 2020 | De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier) | —— | PIERWSZY URZĄD SKARBOWY WARSZAWA-ŚRÓDMIEŚCIE | |
| Sep 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | —— | Prezes Zakładu Ubezpieczeń Społecznych |
Tenders
8 tenders recorded as contractor, with a total value of $8,082,888.
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Oct 1, 2026 | Dostawa różnych produktów leczniczych, w tym cytostatyków, produktów leczniczych z programów lekowych i akcesoriów do receptury dla Copernicus PL Sp. z o.o. | —— | Copernicus Podmiot Leczniczy sp. z o.o. | |
| Jul 8, 2026 | Dostawa leków, środków spożywczych specjalnego przeznaczenia żywieniowego - 197 pakietów | $2.6M$2,555,465 | Szpital Kliniczny Im. Karola Jonschera Uniwersytetu Medycznego Im. Karola Marcinkowskiego w Poznaniu | |
| Jul 8, 2026 | “Dostawa produktów leczniczych (ATC C, B,L), wyrobów medycznych i surowców farmaceutycznych do trzech lokalizacji UCK WUM” | $810.4K$810,373 | Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Authorized Representatives
Manner of representation
In the case of a multi-member management board, the company is represented by two members of the management board acting jointly, or by one member of the management board acting jointly with a commercial proxy. In the case of a one-person management board, the member of the management board acting independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Kamila Anna Bator (49) | 40 | $540.25 | 33.3333% |
Dorota Ciępka (54) | 40 | $540.25 | 33.3333% |
Ewa Paciorek (55) | 40 | $540.25 | 33.3333% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Kamila Bator (49)  | Shareholder of a limited liability company, 2000.0 PLN | |
Dorota Ciępka (54) | Shareholder of a limited liability company, 2000.0 PLN | |
Ewa Paciorek (55) | Shareholder of a limited liability company, 2000.0 PLN |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Anpharm Przedsiębiorstwo FarmaceutyczneS.A. | $111,469,394.21 | anpharm.pl | ||
| Tarchomińskie Zakłady Farmaceutyczne PolfaS.A. | $102,988,448.02 | polfa-tarchomin.com.pl | ||
| VercoS.A. | $43,577,172.02 | verco.com.pl | ||
| MedicofarmaS.A. | $8,530,473.72 | medicofarma.pl | ||
| VitamaS.A. | $4,287,087.38 | vitama.pl | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com | ||
| Stg25Branch (foreign co.) | — | glagolica.eu |
Change history
| Date | Event | |
|---|---|---|
| 2024-02-21 | Share capital change (5,000.00 PLN → 6,000.00 PLN) | |
| 2017-04-05 | Entered in the register |
FAQ
Last updated: 2026-08-21